Compile Data Set for Download or QSAR
Report error Found 299 of affinity data for UniProtKB/TrEMBL: Q92830
TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748489(US20250188030, Compound C71)
Affinity DataKi:  0.0100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748458(US20250188030, Compound C40)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748381(US20250188030, Compound A38)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748380(US20250188030, Compound A37)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748570(US20250188030, Compound I17)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748450(US20250188030, Compound C31)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748527(US20250188030, Compound E3)
Affinity DataKi:  0.0300nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748569(US20250188030, Compound I16)
Affinity DataKi:  0.0300nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748416(US20250188030, Compound B31)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748478(US20250188030, Compound C60)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748472(US20250188030, Compound C54)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748488(US20250188030, Compound C70)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748487(US20250188030, Compound C69)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748420(US20250188030, Compound B35)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748419(US20250188030, Compound B34)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748495(US20250188030, Compound C77)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748508(US20250188030, Compound C90)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748491(US20250188030, Compound C73)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748475(US20250188030, Compound C57)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748423(US20250188030, Compound C3)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748422(US20250188030, Compound C2)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748405(US20250188030, Compound B20)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748461(US20250188030, Compound C43)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748509(US20250188030, Compound C91)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748411(US20250188030, Compound B26)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748455(US20250188030, Compound C37)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748429(US20250188030, Compound C9)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748497(US20250188030, Compound C79)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748479(US20250188030, Compound C61)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748427(US20250188030, Compound C7)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748505(US20250188030, Compound C87)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748485(US20250188030, Compound C67)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748500(US20250188030, Compound C82)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748496(US20250188030, Compound C78)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748401(US20250188030, Compound B16)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748589(US20250188030, Compound J16)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748435(US20250188030, Compound C16)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748528(US20250188030, Compound E4)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748584(US20250188030, Compound J11)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748501(US20250188030, Compound C83)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748481(US20250188030, Compound C63)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748415(US20250188030, Compound B30)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748409(US20250188030, Compound B24)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748456(US20250188030, Compound C38)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748407(US20250188030, Compound B22)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748390(US20250188030, Compound B5)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748440(US20250188030, Compound C21)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748402(US20250188030, Compound B17)
Affinity DataKi:  0.100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748437(US20250188030, Compound C18)
Affinity DataKi:  0.100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandPNGBDBM748471(US20250188030, Compound C53)
Affinity DataKi:  0.100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 299 total ) | Next | Last >>
Jump to: